CAPON Is a Critical Protein in Synaptic Molecular Networks in the Prefrontal Cortex of Mood Disorder Patients and Contributes to Depression-Like Behavior in a Mouse Model.
暂无分享,去创建一个
D. Swaab | Shangfeng Gao | Rutong Yu | P. Lucassen | Dong Liang | Lei Jin | Yunnong Song | Tong Zhang | Guangwei Fan
[1] Qingming Meng,et al. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway. , 2018, Cancer letters.
[2] B. Morentin,et al. Characterisation of spinophilin immunoreactivity in postmortem human brain homogenates , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[3] Liping Chen,et al. Age-dependent differential regulation of anxiety- and depression-related behaviors by neurabin and spinophilin , 2017, PloS one.
[4] R. Sweet,et al. Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease , 2017, Neurobiology of Aging.
[5] Q. Shi,et al. Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway , 2017, Scientific Reports.
[6] Hans-Ulrich Klein,et al. Diurnal and seasonal molecular rhythms in human neocortex and their relation to Alzheimer's disease , 2017, Nature Communications.
[7] R. Verwer,et al. Prefrontal changes in the glutamate-glutamine cycle and neuronal/glial glutamate transporters in depression with and without suicide. , 2016, Journal of psychiatric research.
[8] Lei Jin,et al. Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway , 2016, International journal of molecular sciences.
[9] L. Callado,et al. P.3.e.001 Spinophilin expression in postmortem prefrontal cortex of subjects with schizophrenia: effect of antipsychotic treatment , 2016, European Neuropsychopharmacology.
[10] Shangfeng Gao,et al. Research progress in NOS1AP in neurological and psychiatric diseases , 2016, Brain Research Bulletin.
[11] S. L. la Fleur,et al. Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients. , 2016, The Journal of clinical endocrinology and metabolism.
[12] J. Harro,et al. Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology , 2016, European Neuropsychopharmacology.
[13] B. Firestein,et al. Overexpression of Isoforms of Nitric Oxide Synthase 1 Adaptor Protein, Encoded by a Risk Gene for Schizophrenia, Alters Actin Dynamics and Synaptic Function , 2016, Front. Cell. Neurosci..
[14] J. Nyengaard,et al. Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus , 2016, European Neuropsychopharmacology.
[15] Xin-ming Ma,et al. Dendritic Spines in Depression: What We Learned from Animal Models , 2016, Neural plasticity.
[16] C. P. Morris,et al. Association of NOS1AP variants and depression phenotypes in schizophrenia. , 2015, Journal of affective disorders.
[17] Li-Tao Yi,et al. Fluoxetine regulates mTOR signalling in a region-dependent manner in depression-like mice , 2015, Scientific Reports.
[18] B. Turetsky,et al. Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia , 2015, Schizophrenia Research.
[19] A. Sampson,et al. Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia , 2015, Biological Psychiatry.
[20] D. Swaab,et al. Different stress-related gene expression in depression and suicide. , 2015, Journal of psychiatric research.
[21] R. Duman,et al. Spine synapse remodeling in the pathophysiology and treatment of depression , 2015, Neuroscience Letters.
[22] G. Wegener,et al. Potential roles for Homer1 and Spinophilin in the preventive effect of electroconvulsive seizures on stress-induced CA3c dendritic retraction in the hippocampus , 2015, European Neuropsychopharmacology.
[23] Young Hye Kim,et al. A 3D human neural cell culture system for modeling Alzheimer's disease , 2015, Nature Protocols.
[24] B. Firestein,et al. Nitric Oxide Synthase 1 Adaptor Protein, a Protein Implicated in Schizophrenia, Controls Radial Migration of Cortical Neurons , 2015, Biological Psychiatry.
[25] Michael J Courtney,et al. Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models , 2015, The Journal of Neuroscience.
[26] F. Holsboer,et al. A role for synapsin in FKBP51 modulation of stress responsiveness: Convergent evidence from animal and human studies , 2015, Psychoneuroendocrinology.
[27] J. Coyle,et al. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. , 2014, JAMA psychiatry.
[28] A. Bao,et al. Nitric oxide synthase and nitric oxide alterations in chronically stressed rats: A model for nitric oxide in major depressive disorder , 2014, Psychoneuroendocrinology.
[29] Li-Li Li,et al. Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling , 2014, Front. Cell. Neurosci..
[30] W. Lu,et al. CAPON-nNOS coupling can serve as a target for developing new anxiolytics , 2014, Nature Medicine.
[31] J. Pruessner,et al. Neuropathology of stress , 2013, Acta Neuropathologica.
[32] D. Swaab,et al. Decreased NOS1 expression in the anterior cingulate cortex in depression. , 2013, Cerebral cortex.
[33] P. Licznerski,et al. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression , 2013, Neuroscience.
[34] M. Tremblay,et al. The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive Disorders , 2013, The Journal of Neuroscience.
[35] D. Swaab,et al. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients , 2013, Psychoneuroendocrinology.
[36] C. P. Morris,et al. NOS1AP is associated with increased severity of PTSD and depression in untreated combat veterans. , 2013, Journal of affective disorders.
[37] A. Kalsbeek,et al. Melanocortin 4 receptor distribution in the human hypothalamus. , 2013, European journal of endocrinology.
[38] M. Doucet,et al. Small-Molecule Inhibitors at the PSD-95/nNOS Interface have Antidepressant-Like Properties in Mice , 2013, Neuropsychopharmacology.
[39] G. Rajkowska,et al. Decreased Expression of Synapse-Related Genes and Loss of Synapses in Major Depressive Disorder , 2012, Nature Medicine.
[40] G. Wegener,et al. Wistar rats subjected to chronic restraint stress display increased hippocampal spine density paralleled by increased expression levels of synaptic scaffolding proteins , 2012, Stress.
[41] Adem Can,et al. The mouse forced swim test. , 2011, Journal of visualized experiments : JoVE.
[42] Li-Juan Zhu,et al. Hippocampal Neuronal Nitric Oxide Synthase Mediates the Stress-Related Depressive Behaviors of Glucocorticoids by Downregulating Glucocorticoid Receptor , 2011, The Journal of Neuroscience.
[43] A. Bao,et al. Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[44] S. Buyske,et al. NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia , 2010, Schizophrenia Research.
[45] T. Sharp,et al. Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1 , 2010, Journal of neurochemistry.
[46] F. Benfenati,et al. The synapsins: Key actors of synapse function and plasticity , 2010, Progress in Neurobiology.
[47] Chun Cheng,et al. Inhibition of nitric oxide-induced nuclear localization of CAPON by NMDA receptor antagonist in cultured rat primary astrocytes , 2010, Neurochemistry International.
[48] M. Pompili,et al. Anatomical and functional correlates in major depressive disorder: The contribution of neuroimaging studies , 2010 .
[49] D. Tabb,et al. Identification and Validation of Novel Spinophilin-associated Proteins in Rodent Striatum Using an Enhanced ex Vivo Shotgun Proteomics Approach* , 2010, Molecular & Cellular Proteomics.
[50] F. J. Monje,et al. Rodent models in depression research: Classical strategies and new directions , 2010, Annals of medicine.
[51] B. Firestein,et al. NOS1AP Regulates Dendrite Patterning of Hippocampal Neurons through a Carboxypeptidase E-Mediated Pathway , 2009, The Journal of Neuroscience.
[52] F. Benfenati,et al. Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment , 2008, Journal of Cell Science.
[53] M. Furey,et al. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression , 2008, Brain Structure and Function.
[54] Chun Cheng,et al. Spatiotemporal Expression of Dexras1 After Spinal Cord Transection in Rats , 2008, Cellular and Molecular Neurobiology.
[55] Bin Wang,et al. Neuronal nitric oxide synthase contributes to chronic stress‐induced depression by suppressing hippocampal neurogenesis , 2007, Journal of neurochemistry.
[56] Ho Tak Lau,et al. Micro-dissection of rat brain for RNA or protein extraction from specific brain region. , 2007, Journal of visualized experiments : JoVE.
[57] R. Vertes,et al. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat , 2007, Brain Structure and Function.
[58] G. Rajkowska,et al. Gliogenesis and glial pathology in depression. , 2007, CNS & neurological disorders drug targets.
[59] P. Maycox,et al. Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons , 2006, Molecular and Cellular Neuroscience.
[60] Bin Xu,et al. Increased Expression in Dorsolateral Prefrontal Cortex of CAPON in Schizophrenia and Bipolar Disorder , 2005, PLoS medicine.
[61] A. Bassett,et al. Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. , 2004, American journal of human genetics.
[62] M. León‐Olea,et al. Nitric oxide synthase inhibition during synaptic maturation decreases synapsin I immunoreactivity in rat brain. , 2004, Nitric oxide : biology and chemistry.
[63] P. Greengard,et al. Subcellular distribution of spinophilin immunolabeling in primate prefrontal cortex: Localization to and within dendritic spines , 2004, The Journal of comparative neurology.
[64] P. Goldman-Rakic,et al. Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. , 2003, Archives of general psychiatry.
[65] Sabine Landau,et al. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. , 2002, Cerebral cortex.
[66] A. Czernik,et al. Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] R. Kerwin,et al. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. , 2001, Archives of general psychiatry.
[68] L. Selemon,et al. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder , 2001, Biological Psychiatry.
[69] P. Greengard,et al. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex , 2001, Biological Psychiatry.
[70] P. Greengard,et al. Spinophilin regulates the formation and function of dendritic spines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[71] G. Rosoklija,et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. , 2000, Archives of general psychiatry.
[72] B. Roth,et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.
[73] W. Kamphorst,et al. Comparison of β-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer’s disease patients: amorphic plaques and cytoskeletal changes occur independently , 1998, Acta Neuropathologica.
[74] S. Snyder,et al. CAPON: A Protein Associated with Neuronal Nitric Oxide Synthase that Regulates Its Interactions with PSD95 , 1998, Neuron.
[75] P. Greengard,et al. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[76] D. Swaab,et al. The art of matching brain tissue from patients and controls for postmortem research. , 2018, Handbook of clinical neurology.
[77] D. Swaab,et al. Abnormal retinoid and TrkB signaling in the prefrontal cortex in mood disorders. , 2015, Cerebral cortex.
[78] C. Portugal,et al. Nitric oxide in the nervous system: biochemical, developmental, and neurobiological aspects. , 2014, Vitamins and hormones.
[79] D. Swaab,et al. Neurotransmitters and neuropeptides in depression. , 2012, Handbook of clinical neurology.
[80] Wei Zhang,et al. Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia , 2009, Neuropsychopharmacology.
[81] E. Batschelet. Circular statistics in biology , 1981 .